Literature DB >> 215496

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

P J Johnson, N Krasner, B Portmann, A L Eddleston, R Williams.   

Abstract

An analysis of 294 patients who died with cirrhosis showed that 24% had developed hepatocellular carcinoma. Haemochromatosis and HBsAg positive chronic active hepatitis were high risk groups (36% and 42% respectively) and the frequency was lowest in primary biliary cirrhosis and HBsAg negative chronic active hepatitis (3% and 11% respectively). Those with hepatocellular carcinoma showed a striking male preponderance (11:1) and further analysis has shown that the proportion developing this tumour in each group was closely related to the proportion of males in that group (r=0.97). Age was the only other significant factor, malignant change occurring more commonly in those over the age of 50 years than those below (30% and 7% respectively, P less than 0.005). The indluence of HBsAg was largely accounted for by the known predisposition of males to carry HBsAg. The group of patients who had developed this tumour without cirrhosis were younger (mean age 39 years) and had a lower male to female ratio of 1.1:1 and the place of contraceptive-related tumour within this group is dicussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215496      PMCID: PMC1412242          DOI: 10.1136/gut.19.11.1022

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis.

Authors:  E A GALL
Journal:  Arch Pathol       Date:  1960-08

2.  The incidence of primary hepatic carcinoma in cirrhosis.

Authors:  R G PARKER
Journal:  Proc R Soc Med       Date:  1957-03

3.  The incidence of spontaneous hepatomas in C3H, C3H (low milk factor), and CBA mice and the effect of estrogen and androgen on the occurrence of these tumors in C3H mice.

Authors:  L R C AGNEW; W U GARDNER
Journal:  Cancer Res       Date:  1952-10       Impact factor: 12.701

4.  Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

Authors:  M J Tong; S C Sun; B T Schaeffer; N K Chang; K J Lo; R L Peters
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

5.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

6.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

7.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

8.  Cirrhosis of the liver. A comparative study of the four major aetiological groups.

Authors:  L W Powell; R Mortimer; O D Harris
Journal:  Med J Aust       Date:  1971-05-01       Impact factor: 7.738

9.  LETTER: Liver tumours and oral contraceptives.

Authors:  W M Christopherson; E T Mays
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

10.  Long term results of venesection therapy in idiopathic haemochromatosis.

Authors:  A Bomford; R Williams
Journal:  Q J Med       Date:  1976-10
View more
  28 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Potential hazards of intraoperative cholangiography in patients with infected bile.

Authors:  G S McIntosh
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

Review 3.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.

Authors:  Qing Wei; Pengbo Guo; Kun Mu; Ying Zhang; Wei Zhao; Wanwan Huai; Yumin Qiu; Tao Li; Xiaomin Ma; Yafei Liu; Xiaoyan Chen; Lihui Han
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

5.  Cirrhosis and hepatocellular carcinoma: a 13 year necropsy study with attention to the role of alcohol.

Authors:  G S McDonald; G P Boran; D G Weir
Journal:  Ir J Med Sci       Date:  1985-04       Impact factor: 1.568

6.  Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.

Authors:  Nan Mei; Robert H Heflich; Martha M Moore; Tao Chen
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

7.  Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain.

Authors:  P J Baxter; P P Anthony; R N Macsween; P J Scheuer
Journal:  Br J Ind Med       Date:  1980-08

8.  Primary liver cell carcinoma complicating autoimmune chronic active hepatitis.

Authors:  A W Jakobovits; P R Gibson; F J Dudley
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

9.  Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.

Authors:  P J Jenkins; W M Melia; B Portmann; J M Longworth Krafft; R Williams
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

10.  7-Ethoxyresorufin deethylase (EROD) in human liver--the effect of alcoholic liver disease.

Authors:  K W Woodhouse; E Mutch; F M Williams; O F James; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.